INTS13 and cervical carcinoma: In vitro functional studies corroborated these findings, demonstrating that genetic silencing or CRISPR/Cas9-mediated knockout of INTS13 markedly inhibited the proliferation, migration, and invasion of primary cervical cancer cells while selectively inducing apoptosis.